This webinar is sponsored by Regeneron and Sanofi. Discover a breakthrough treatment in COPD! Join our lively discussion on the management of patients with a history of exacerbations. Learn about a treatment option targeting inflammation, supported by clinical data from two Phase 3 studies, and have your questions answered. By registering for this webinar, you agree your information will be shared with the sponsor.
No CME or MOC credits are available for this program. Opinions expressed and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.